EFFICACY OF TERIPARATIDE ON OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ∼IS IT APPROPRIATE TO PRESCRIBE TERIPARATIDE TOGETHER WITH BIOLOGICAL AGENTS?

被引:0
|
作者
Hirano, Y. [1 ]
Oishi, Y. [1 ]
Takemoto, G. [1 ]
Kojima, T. [2 ]
Ishiguro, N. [2 ]
机构
[1] Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:304 / 304
页数:1
相关论文
共 50 条
  • [41] Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy
    N. Nasomyont
    C. Keefe
    C. Tian
    L. Hornung
    J. Khoury
    J. C. Tilden
    P. Hochwalt
    E. Jackson
    I. Rybalsky
    B. L. Wong
    M. M. Rutter
    Osteoporosis International, 2020, 31 : 2449 - 2459
  • [42] Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in rheumatoid arthritis patients
    Mokuda, S.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (04) : 1443 - 1443
  • [43] PINP as a biological response marker during teriparatide treatment for osteoporosis
    Krege, J. H.
    Lane, N. E.
    Harris, J. M.
    Miller, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (09) : 2159 - 2171
  • [44] PINP as a biological response marker during teriparatide treatment for osteoporosis
    J. H. Krege
    N. E. Lane
    J. M. Harris
    P. D. Miller
    Osteoporosis International, 2014, 25 : 2159 - 2171
  • [45] P112 Teriparatide versus anti-resorptive treatment in rheumatoid arthritis patients with severe osteoporosis: an observational study
    Hauser, Barbara
    Berg, Kathryn M.
    Lambert, Justine A.
    Ralston, Stuart H.
    RHEUMATOLOGY, 2021, 60
  • [46] OUR EXPERIENCE WITH TERIPARATIDE (FORSTEO) IN PATIENTS WITH SEVERE OSTEOPOROSIS
    Popova, V. P.
    Popova, M. P. Gebeva
    Vazhev, Z. V.
    Ronchev, Y. R.
    Kraev, K. K.
    Batalov, A. B.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S231 - S232
  • [47] Adherence and persistence in patients with severe osteoporosis treated with teriparatide
    Ziller, V.
    Zimmermann, S. P.
    Kalder, M.
    Ziller, M.
    Sekar-Pektas, B.
    Hellmeyer, L.
    Hadji, P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 675 - 681
  • [48] Adherence in Patients with Severe Osteoporosis Treated with Teriparatide.
    Ziller, V.
    Zimmemann, S.
    Hadji, P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S470 - S470
  • [49] Contributors to Secondary Osteoporosis in Patients Referred for Treatment with Teriparatide
    Anaforoglu, Inan
    Asik, Mehmet
    Ersoy, Kerem
    Kose, Mustafa
    Ayhan, Semiha
    Algun, Ekrem
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 17 (04) : 98 - 101
  • [50] Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis
    Ebina, Kosuke
    Hirao, Makoto
    Hashimoto, Jun
    Hagihara, Keisuke
    Kashii, Masafumi
    Kitaguchi, Kazuma
    Matsuoka, Hozo
    Iwahashi, Toru
    Chijimatsu, Ryota
    Yoshikawa, Hideki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2018, 36 (04) : 478 - 487